Announcing the Launch of "Dermarin Cool Powder"
Athlete’s Foot Treatment for Women

Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) will launch "Dermarin Cool Powder", an athlete’s foot treatment aimed at women users, on March 14.

A survey of women users of athlete’s foot treatments reveals that the characteristics that women require of an athlete’s foot treatment are effective action, together with a sense of hygiene and a fresh feel in use.

The active ingredients of "Dermarin Cool Powder" include miconazole nitrate, a compound with an outstanding antifungal action and a strong track record established under the "Dermarin" brand, decalinium chloride, an antibacterial agent that keeps the affected area clean, and lidocaine, which prevents itching. The product is supplied in powder spray format which means that it can be applied without touching the affected area directly, making for a sense of hygiene, and gives a pleasantly dry feel. The package, a pearl white and pink can, has also been designed with women users in mind.

Since 1988, when the athlete’s foot treatment "Dermarin", the first athlete’s foot treatment to incorporate the prescription drug miconazole nitrate for use in an OTC drug, Taisho has expanded the "Dermarin" series by through the developing of new product formats, such as sprays, and modifying initial prescriptions. The launch of "Dermarin Cool Powder" is part of Taisho’s ongoing response to ever-diversifying users' needs.